Table 3.
Quality‐of‐life scores on each scale, using DLQI, SF‐36 and EQ‐5D‐3L questionnaires among patients with plaque‐type psoriasis in a Brazilian population
| HRQoL measure | Dimension | Mean | SD |
|---|---|---|---|
| DLQI (n = 292) | Symptoms and feelings (maximum = 6) | 2.1 | 1.7 |
| Daily activities (maximum = 6) | 1.5 | 1.8 | |
| Leisure (maximum = 6) | 1.3 | 1.7 | |
| Personal relationships (maximum = 6) | 0.8 | 1.5 | |
| Work and school (maximum = 3) | 0.4 | 0.8 | |
| Treatment (maximum = 3) | 0.4 | 0.7 | |
| Total (maximum = 30) | 6.5 | 6.9 | |
| SF‐36 (n = 292) | Vitality (0–100) | 50.6 | 11.2 |
| General health (0–100) | 45.1 | 11.0 | |
| Role‐physical (0–100) | 44.8 | 11.8 | |
| Social functioning (0–100) | 44.4 | 12.3 | |
| Mental health (0–100) | 44.1 | 12.8 | |
| Physical functioning (0–100) | 44.0 | 11.4 | |
| Bodily pain (0–100) | 43.9 | 11.6 | |
| Role‐emotional (0–100) | 43.5 | 12.6 | |
| Physical component summary score (0–100) | 45.2 | 10.4 | |
| Mental component summary score (0–100) | 45.5 | 12.3 | |
| EQ‐5D‐3L (n = 286) | Utility score (0–1) | 0.68 | 0.27 |
| Overall value (0–100) | 72.7 | 19.7 |
DLQI, Dermatology Life Quality Index; EQ‐5D‐3L, EuroQol Five‐Dimension Questionnaire Three‐Level version; SD, standard deviation; SF‐36, 36‐Item Short Form Health Survey.